Form 4 · Statement of Changes in Beneficial Ownership · Filed 2026-09-12
Azar Alex M Ii Files Guardant Health (GH) Form 4 - September 12, 2026
Azar Alex M Ii bought 1.7K GH shares in this Form 4 filing, reported to the SEC on 2026-09-12.
- Insider
- Azar Alex M Ii
- Issuer
- Guardant Health Inc. GH · NASDAQ
- Filed
- Period
- 2026-09-12
- Accession
- 0001402256-26-000004
- Source
- Official filing on sec.gov ↗
Transactions (2)
| Insider | Date | Type | Shares | Price | Value | Own |
|---|---|---|---|---|---|---|
| Azar Alex M Ii | 2026-09-12 | Buy | 1.7K | $0.00 | $0.00 | Direct |
| Net change | +1.7K | $0.00 | ||||
About Guardant Health Inc.
Guardant Health Inc. is a precision oncology company that develops blood- and tissue-based tests, data sets, and analytics to support cancer detection and treatment decisions. Its product portfolio includes liquid biopsy tests for tumor mutation profiling, molecular residual disease monitoring, tissue-based genomic profiling, and colorectal cancer screening. The company’s solutions are used across clinical care and research settings to help identify biomarkers, track recurrence, and provide molecular insights from tumor-derived material. Guardant Health serves healthcare providers, laboratories, researchers, and life sciences partners in the United States and internationally, with a focus on noninvasive diagnostics and cancer monitoring. Headquartered in Palo Alto, California, Guardant Health plays a significant role in the growing market for precision medicine and advanced oncology diagnostics.
Track GH insider activity
Get alerted when Guardant Health Inc. executives buy or sell their shares.